News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: corporalagarn post# 146951

Thursday, 10/31/2013 2:28:26 PM

Thursday, October 31, 2013 2:28:26 PM

Post# of 347009

"as I am still trying to discover the reasons for much of the BOD/CEO bashing going on the last several years"

I'll help you out, look at the pps chart and then look at BOD/CEO salaries and option awards. See if anything jumps out at you.



With every action there is an equal and opposite reaction.

I look at the pps and yes, I don't like it. Anyone can come here everyday and complain about it or try to solve why the price is the way it is. Peregrine announced "Clear Evidence of Dose Switching" and just a week ago at the Annual Shareholders Meeting SK says that things have been referred to the FDA and "several" other Federal Authorities. Corp... one can continue to complain or start realizing "with every action is an equal and opposite reaction".

Now, you telling me that seeing "Peter Cohen" who now works for "Roswell Capital Management" and previously worked for "CarMax", the same place that Lynn Mussatt works and is President-- related to Jeffrey Mussatt -- brother of David Mussatt..etc..etc...and etc... and thats enough to spread enough puzzle pieces out for hundreds of people long. Even if only 10 of them matter... all must be looked at.


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y